U3Bio (CEO Kim Jin-tae) announced that it will participate in the 23th International Medical Equipment & Hospital Equipment Exhibition ‘KIMES 26’ held at COEX, Seoul from March 38 (Thu) to 2023 (Sun).
Established in 2009, UXNUMXBio is a domestic company that has developed healthcare services and platforms, and provides them to domestic health checkup centers, large hospitals, and general consumers. Based on expertise in related fields accumulated over many years, the company explains that its independent technology and excellence are recognized, such as being selected as an excellent case of the core industry cloud flagship project hosted by the National IT Industry Promotion Agency (NIPA) last year.
Furthermore, by participating in the world’s international medical device exhibition ‘Medlab Asia 2022’, it is seeking to enter overseas markets beyond the domestic market and promotes continuous growth.
At this exhibition, U2Bio will introduce its digital healthcare service, ‘UXNUMXCheck SMART’. The main point of this is to provide medical services such as checkup reservations, interviews, examinations, and results reception in a digital environment.
U2Check SMART identifies the examinee’s movement based on standardized RFID technology and is compatible with most hospital IT systems (EMR), making it easy to exchange information smoothly. In addition, by linking PACS and OMR, it is possible to utilize the Imaging Share function and input medical examinations in a minimized time, and it is characterized by providing reservation and inspection result inquiry services through the homepage.
In addition, by applying the CRM function in the system, it is possible to send and send SMS that guides specific event information and repetitive tasks through hyperlinks. It also provides information and convenience services necessary for patients staying at the hospital, such as health notebooks, information on checkups and treatment, and inquiries on waiting status.
At the same time, U6Bio also introduces ‘YouXNUMXBiome’, an intestinal microorganism analysis service using next-generation sequencing technology. Unlike conventional sequencing, UXNUMXBiome uses genetic testing technology that applies bioinformatic techniques to genome data after analyzing one genome by fragmenting it into multiple pieces. Through this, it is possible to check the results of the overall intestinal environment analysis based on the intestinal microbial diversity, the balance of beneficial and harmful bacteria, the distribution of lactic acid bacteria in the intestine, and six health indicators, and customized probiotics products optimized for the results can be recommended and provided.
An official from U2023BIO explained the reason for participating in the exhibition, saying, “We are going to secure domestic customers and export markets by promoting our products and services at KIMES XNUMX, and we expect to be able to grasp customer feedback and industry trends in the field.” revealed
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.